CryoCor (CRYO) Misses Q4 EPS by 2c
CryoCor, Inc. (Nasdaq: CRYO) reports a Q4 loss of $0.35, 2 cents worse than estimates. Revenues were $240K vs. $300K consensus.
CryoCor, Inc. has developed and manufactured a minimally invasive system based on its cryoablation technology for the treatment of cardiac arrhythmias.[SM]
CryoCor, Inc. has developed and manufactured a minimally invasive system based on its cryoablation technology for the treatment of cardiac arrhythmias.[SM]
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
